Xylem Inc. (XYL) Expected to Announce Earnings of $0.51 Per Share

Equities research analysts expect Xylem Inc. (NYSE:XYL) to announce earnings of $0.51 per share for the current quarter, according to Zacks. Six analysts have issued estimates for Xylem’s earnings, with the lowest EPS estimate coming in at $0.50 and the highest estimate coming in at $0.53. Xylem posted earnings per share of $0.39 in the same quarter last year, which suggests a positive year over year growth rate of 30.8%. The company is scheduled to report its next earnings report before the market opens on Tuesday, May 1st.

According to Zacks, analysts expect that Xylem will report full year earnings of $2.92 per share for the current year, with EPS estimates ranging from $2.87 to $2.95. For the next financial year, analysts expect that the company will report earnings of $3.38 per share, with EPS estimates ranging from $3.26 to $3.56. Zacks’ earnings per share calculations are a mean average based on a survey of sell-side analysts that follow Xylem.

How to Become a New Pot Stock Millionaire

Xylem (NYSE:XYL) last issued its earnings results on Thursday, February 1st. The industrial products company reported $0.76 EPS for the quarter, hitting the consensus estimate of $0.76. The company had revenue of $1.28 billion during the quarter, compared to analyst estimates of $1.27 billion. Xylem had a return on equity of 17.95% and a net margin of 7.03%. The business’s revenue was up 16.6% on a year-over-year basis. During the same quarter last year, the firm earned $0.66 EPS.

Several research analysts have recently commented on XYL shares. Zacks Investment Research lowered Xylem from a “buy” rating to a “hold” rating in a research report on Monday, January 22nd. Royal Bank of Canada restated a “buy” rating and set a $80.00 price objective on shares of Xylem in a research report on Thursday, January 4th. Oppenheimer boosted their price objective on Xylem to $82.00 and gave the company an “outperform” rating in a research report on Friday, February 2nd. ValuEngine upgraded Xylem from a “hold” rating to a “buy” rating in a research report on Thursday, March 1st. Finally, Cowen restated a “buy” rating and set a $80.00 price objective on shares of Xylem in a research report on Tuesday, March 6th. Five research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus price target of $74.00.

In other Xylem news, insider Tomas Brannemo sold 1,151 shares of the business’s stock in a transaction on Tuesday, February 27th. The stock was sold at an average price of $76.41, for a total transaction of $87,947.91. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Curtis J. Crawford sold 7,948 shares of the business’s stock in a transaction on Thursday, February 8th. The stock was sold at an average price of $71.77, for a total value of $570,427.96. Following the transaction, the director now owns 55,245 shares of the company’s stock, valued at approximately $3,964,933.65. The disclosure for this sale can be found here. Insiders have sold a total of 21,105 shares of company stock valued at $1,540,907 in the last 90 days. Insiders own 0.81% of the company’s stock.

A number of hedge funds have recently made changes to their positions in the business. BlackRock Inc. boosted its position in Xylem by 16.0% during the 4th quarter. BlackRock Inc. now owns 14,130,060 shares of the industrial products company’s stock worth $963,668,000 after acquiring an additional 1,949,335 shares during the period. Parnassus Investments CA boosted its position in Xylem by 0.8% during the 4th quarter. Parnassus Investments CA now owns 6,063,309 shares of the industrial products company’s stock worth $413,518,000 after acquiring an additional 48,919 shares during the period. Geode Capital Management LLC boosted its position in Xylem by 5.5% during the 4th quarter. Geode Capital Management LLC now owns 2,027,704 shares of the industrial products company’s stock worth $138,016,000 after acquiring an additional 106,271 shares during the period. KAMES CAPITAL plc boosted its position in Xylem by 16.1% during the 4th quarter. KAMES CAPITAL plc now owns 1,098,865 shares of the industrial products company’s stock worth $74,943,000 after acquiring an additional 152,355 shares during the period. Finally, Chilton Investment Co. LLC boosted its position in Xylem by 0.6% during the 4th quarter. Chilton Investment Co. LLC now owns 982,583 shares of the industrial products company’s stock worth $67,012,000 after acquiring an additional 5,627 shares during the period. Institutional investors own 86.02% of the company’s stock.

Shares of XYL opened at $78.88 on Wednesday. The company has a market capitalization of $13,821.18, a PE ratio of 32.87, a PEG ratio of 1.48 and a beta of 1.10. The company has a quick ratio of 1.41, a current ratio of 1.88 and a debt-to-equity ratio of 0.87. Xylem has a 52 week low of $48.97 and a 52 week high of $79.83.

COPYRIGHT VIOLATION WARNING: “Xylem Inc. (XYL) Expected to Announce Earnings of $0.51 Per Share” was reported by Week Herald and is the sole property of of Week Herald. If you are accessing this piece on another website, it was stolen and reposted in violation of U.S. and international copyright and trademark legislation. The original version of this piece can be viewed at https://weekherald.com/2018/04/18/xylem-inc-xyl-expected-to-announce-earnings-of-0-51-per-share.html.

About Xylem

Xylem Inc engages in the design, manufacture, and service of engineered solutions for the water and wastewater applications. It operates through three segments: Water Infrastructure, Applied Water, and Measurement and Control Solutions. The Water Infrastructure segment offers various products, including water and wastewater pumps, and controls and systems, as well as filtration, disinfection, and biological treatment equipment under the Flygt, Godwin, Wedeco, Sanitaire, and Leopold names for the transportation, treatment, and testing of water and wastewater applications.

Get a free copy of the Zacks research report on Xylem (XYL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply